{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Week in Review Desk", "lead_paragraph": "AMERICANS have become used to the idea that medical treatments should be carefully tested to assure that they work and are safe. So there was surprise the last two weeks as two widely accepted practices were upended by researchers after they had affected the lives of millions of people. In one case, the popular diet drugs Redux and Pondimin were pulled off the market because of studies suggesting they may cause serious heart problems. The Food and Drug Administration had agonized for years before approving the drugs only for treating the obese. But soon doctors were writing more than 18 million prescriptions a year, many for people who just wanted to lose a few pounds.", "headline": {"main": "The Nation; Medicine Remains as Much Art as Science"}, "abstract": "Medical experts estimate that half of all surgical operations and other medical procedures remain without strict scientific evidence of their efficacy and safety; effort to test medical treatments has never caught up with large number of procedures, drugs and devices that continue to be created at fast pace in health-conscious end of century; experts say more evidence is needed, and people should realize that much of medicine is art rather than science; photo (M)", "print_page": "5", "word_count": 989, "_id": "4fd1fee18eb7c8105d760189", "snippet": "AMERICANS have become used to the idea that medical treatments should be carefully tested to assure that they work and are safe. So there was surprise the last two weeks as two widely accepted practices were upended by researchers after they had...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1997/09/21/weekinreview/the-nation-medicine-remains-as-much-art-as-science.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "RESEARCH"}, {"name": "subject", "value": "TESTS AND TESTING"}, {"name": "subject", "value": "SURGERY AND SURGEONS"}], "byline": {"person": [{"firstname": "Philip", "middlename": "J.", "lastname": "HILTS", "rank": 1, "role": "reported", "organization": ""}], "original": "By PHILIP J. HILTS"}, "document_type": "article", "pub_date": "1997-09-21T00:00:00Z", "section_name": "Health; Week in Review"}, {"type_of_material": "News", "blog": [], "news_desk": "Science Desk", "lead_paragraph": "A NEW study supports the value of stimulant drugs in treating children with attention deficit hyperactivity disorder, although scientists caution that the drugs may already be overused in this country. It adds new information to the debate raging over the use of such drugs, which has nearly tripled since 1990. The study is the only controlled clinical trial to show long-term improvements in children with the disorder who used stimulant medication, the researchers said. It followed Swedish children for 15 months and found that those who used a stimulant had fewer symptoms and greater improvements on an intelligence test than a comparison group. The study appears in the current issue of Archives of General Psychiatry.", "headline": {"main": "Study Supports Use of Stimulants For Children With Hyperactivity"}, "abstract": "Swedish study finds long-term improvements in children with attention deficit hyperactivity disorder who are treated with stimulant drugs; previous research showed benefits from stimulants like Ritalin, but only followed children for short periods (M)", "print_page": "10", "word_count": 856, "_id": "4fd1e25f8eb7c8105d72b29d", "snippet": "A NEW study supports the value of stimulant drugs in treating children with attention deficit hyperactivity disorder, although scientists caution that the drugs may already be overused in this country.    It adds new information to the debate raging...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1997/09/16/science/study-supports-use-of-stimulants-for-children-with-hyperactivity.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "glocations", "value": "SWEDEN"}, {"name": "subject", "value": "ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADD)"}, {"name": "subject", "value": "HYPERACTIVITY"}, {"name": "subject", "value": "CHILDREN AND YOUTH"}, {"name": "subject", "value": "RITALIN (DRUG)"}, {"name": "subject", "value": "MENTAL HEALTH AND DISORDERS"}, {"name": "subject", "value": "AMPHETAMINES"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Susan", "lastname": "GILBERT"}], "original": "By SUSAN GILBERT"}, "document_type": "article", "pub_date": "1997-09-16T00:00:00Z", "section_name": "Science; Health"}], "meta": {"hits": 2, "offset": 0, "time": 300}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}